Research output per year
Research output per year
Fingerprint
Dive into the research topics where Nobuyuki Shimono is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Impact of NAFLD-related SNPs on the carotid atherosclerosis development; a five-year prospective observational study
Ikezaki, H., Nakashima, R., Matsumoto, Y., Ohta, A., Yamasaki, S., Hiramine, S., Takayama, K., Ogawa, E., Masayuki, M., Furusyo, N., Hayashi, J., Shimono, N. & Schaefer, E. J., Mar 2025, In: Atherosclerosis Plus. 59, p. 10-17 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A delayed diagnosis of fascioliasis: The importance of appropriate fecal diagnostic method
Kosaka, S., Shimizu, S., Nakayamada, S., Nawata, A., Shimono, N., Tanaka, M., Maruyama, H., Osada, Y. & Tanaka, Y., May 2024, In: Journal of Infection and Chemotherapy. 30, 5, p. 454-458 5 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Clinical and virological features of SARS-CoV-2 Omicron variant-infected immunocompromised patients receiving immunosuppressive medications
Nakamura, K., Goto, T., Shiraishi, K., Yonekawa, A., Eriguchi, Y., Akashi, K., Shimono, N. & Chong, Y., Dec 2024, In: BMC Infectious Diseases. 24, 1, 736.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Corrigendum to “The humoral and cellular immune responses following booster vaccination with SARS-CoV-2 mRNA in people living with human immunodeficiency virus” [J. Infect. Chemother. 30 (2024) 417–422, (S1341321X23002866), (10.1016/j.jiac.2023.11.014)]
Matsumoto, Y., Murata, M., Ohta, A., Yamasaki, S., Ikezaki, H., Toyoda, K. & Shimono, N., Nov 2024, In: Journal of Infection and Chemotherapy. 30, 11, p. 1198 1 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Immunosuppressive therapy and humoral response to third mRNA COVID-19 vaccination with a six-month interval in rheumatic disease patients
Kashiwado, Y., Kimoto, Y., Ohshima, S., Sawabe, T., Irino, K., Nakano, S., Hiura, J., Yonekawa, A., Wang, Q., Doi, G., Ayano, M., Mitoma, H., Ono, N., Arinobu, Y., Niiro, H., Hotta, T., Kang, D., Shimono, N., Akashi, K. & Takeuchi, T. & 1 others, , Mar 1 2024, In: Rheumatology (United Kingdom). 63, 3, p. 725-733 9 p.Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus)
Activities
- 1 Oral presentation
-
当院における遠隔医療相談への取り組み
Sagara, R. (Speaker), 時穎 (Speaker), 松本美佳 (Speaker), Kudo, K. (Speaker), Shimono, N. (Speaker), Nakashima, N. (Speaker) & Shimizu, S. (Speaker)
Nov 9 2018 → Nov 10 2018Activity: Talk or presentation types › Oral presentation